Post-Bariatric Surgery Statin Discontinuation and ASCVD Risk

Post-bariatric surgery statin discontinuation poses significant risks for ASCVD events, particularly in patients with prior ASCVD and certain demographics like Hispanics. Primary prevention patients have an 82% reduced risk of post-statin cessation ASCVD events compared to secondary prevention patients. Individualized healthcare strategies are needed, especially for those over age 40 with diabetes. Comprehensive cardiovascular evaluations are crucial for making optimal decisions regarding statin cessation.